Takahiro Matsushige1, Satoshi Kuwamoto2,3, Michiko Matsushita1, Lusi Oka Wardhani3, Yasushi Horie2, Kazuhiko Hayashi3, Yukisato Kitamura1. 1. Department of Pathobiological Science and Technology, Major in Clinical Laboratory Science, School of Health Science, Tottori University Faculty of Medicine, Yonago 683-8503, Japan. 2. †Department of Pathology, Tottori University Hospital, Yonago 683-8504, Japan. 3. ‡Division of Molecular Pathology, Department of Pathology, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
Abstract
BACKGROUND: Recent rapid advances in molecular biology have led the discovery of disease-specific novel fusion genes in a variety of soft tissue tumors. In this study, we attempted to detect these fusion genes using formalin-fixed paraffin-embedded (FFPE) tumor tissues and investigated their clinical utility and factors that affect the results of examination. METHODS: Reverse transcription polymerase chain reaction for the detection of tumor-specific fusion genes was performed using 41 FFPE tumor samples obtained from 37 patients representing nine histological types of soft tissue tumors that were diagnosed from 2006 to 2017 in our laboratory. RESULTS: Fusion genes in 19 (51.3%) out of 37 cases were detected successfully. Relatively high detection rates were observed in synovial sarcomas (100%, 4/4) and alveolar rhabdomyosarcomas (75%, 3/4). The detection rates of fusion genes were inversely correlated with the storage period of FFPE blocks. Decalcification by Plank-Rychlo solution significantly affected detection rates of the internal control gene (P = 0.0038). In contrast, there was no significant difference in detection rates between primary and metastatic lesion, or biopsy and resection material, or presence and absence of treatment history. CONCLUSION: In certain histological types, detection of disease-specific fusion genes of soft tissue tumors using FFPE tissues showed high sensitivity and thus had diagnostic utility. However, due to the diversity of fusion patterns and the low-quality of nucleic acid, the detection rate as a whole was sluggish and required further improvement. For factors affecting the detection results, our results suggested that it was impossible to detect fusion genes by decalcified FFPE tissues, but it may be not necessary to consider factors such as the type of specimen (biopsy or resection) and treatment history of the patients when selecting the FFPE tissues.
BACKGROUND: Recent rapid advances in molecular biology have led the discovery of disease-specific novel fusion genes in a variety of soft tissue tumors. In this study, we attempted to detect these fusion genes using formalin-fixed paraffin-embedded (FFPE) tumor tissues and investigated their clinical utility and factors that affect the results of examination. METHODS: Reverse transcription polymerase chain reaction for the detection of tumor-specific fusion genes was performed using 41 FFPE tumor samples obtained from 37 patients representing nine histological types of soft tissue tumors that were diagnosed from 2006 to 2017 in our laboratory. RESULTS: Fusion genes in 19 (51.3%) out of 37 cases were detected successfully. Relatively high detection rates were observed in synovial sarcomas (100%, 4/4) and alveolar rhabdomyosarcomas (75%, 3/4). The detection rates of fusion genes were inversely correlated with the storage period of FFPE blocks. Decalcification by Plank-Rychlo solution significantly affected detection rates of the internal control gene (P = 0.0038). In contrast, there was no significant difference in detection rates between primary and metastatic lesion, or biopsy and resection material, or presence and absence of treatment history. CONCLUSION: In certain histological types, detection of disease-specific fusion genes of soft tissue tumors using FFPE tissues showed high sensitivity and thus had diagnostic utility. However, due to the diversity of fusion patterns and the low-quality of nucleic acid, the detection rate as a whole was sluggish and required further improvement. For factors affecting the detection results, our results suggested that it was impossible to detect fusion genes by decalcified FFPE tissues, but it may be not necessary to consider factors such as the type of specimen (biopsy or resection) and treatment history of the patients when selecting the FFPE tissues.
Authors: Martin P Powers; Wei-Lien Wang; Vivian S Hernandez; Kayuri S Patel; Dina C Lev; Alexander J Lazar; Dolores H López-Terrada Journal: Mod Pathol Date: 2010-06-25 Impact factor: 7.842
Authors: Gino R Somers; Sandra Viero; Paul C Nathan; Ikuko Teshima; Carlos Pereira; Maria Zielenska Journal: Am J Surg Pathol Date: 2005-12 Impact factor: 6.394
Authors: Poul H B Sorensen; James C Lynch; Stephen J Qualman; Roberto Tirabosco; Jerian F Lim; Harold M Maurer; Julia A Bridge; William M Crist; Timothy J Triche; Frederic G Barr Journal: J Clin Oncol Date: 2002-06-01 Impact factor: 44.544
Authors: Karolin H Hallor; Francesca Micci; Jeanne M Meis-Kindblom; Lars-Gunnar Kindblom; Patrizia Bacchini; Nils Mandahl; Fredrik Mertens; Ioannis Panagopoulos Journal: Cancer Lett Date: 2006-12-22 Impact factor: 8.679
Authors: Cristina R Antonescu; Paola Dal Cin; Khedoudja Nafa; Lisa A Teot; Urvashi Surti; Christopher D Fletcher; Marc Ladanyi Journal: Genes Chromosomes Cancer Date: 2007-12 Impact factor: 5.006